Non-alcoholic fatty liver disease resolution following sleeve gastrectomy
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background Non-alcoholic fatty liver disease (NAFLD), a disease highly prevalent among the morbidly obese population, is one of the most common causes of chronic liver disease today. The purpose of this study was to observe the effect of laparoscopic sleeve gastrectomy (LSG) on the resolution of NAFLD. Methods A retrospective study was conducted of 84 patients diagnosed with NAFLD prior to undergoing LSG. The diagnosis of NAFLD was achieved based on transabdominal ultrasonographic imaging as per the 2012 joint guidelines for the diagnosis of NAFLD (American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology). The patients had follow-up anthropometric measurements and were re-evaluated with postoperative ultrasounds at different time frames to assess the resolution of the disease. Results The median age of the patients was 44 (17-62), and 66.7 % were female. Average time since surgery was 3.3 years (range 1-5 years). The mean pre- and postoperative BMIs were 46.6 ± 7.8 and 33.0 ± 7.1, respectively, with a mean percent excess weight loss (%EWL) of 55.7 % ± 23.0. A total of 47 (56 %) patients showed complete resolution of NAFLD postoperatively. Multivariate analysis showed a significant resolution of NAFLD in patients achieving >50 % EWL (OR 10.1; p Conclusions Weight loss after LSG effectively resolved NAFLD in more than half of the obese patients in this study and can prove to be a useful tool in tack…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with a highly significant association between NAFLD remission and achieving greater than 50% excess weight loss (odds ratio 10.1, p < 0.001)”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [38]
In the citing paper
“a retrospective analysis by Algooneh et al. reported remission of NAFLD in 56% of patients undergoing VSG”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [38]
In the citing paper
“VSG showed similar efficacy, with 56–68.4% achieving remission [38,118].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [38]
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803 · cited 2×
“The diagnosis of NAFLD was achieved based on transabdominal ultrasonographic imaging, as per the 2012 joint guidelines for the diagnosis of NAFLD [15].”
MethodVernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074 · cited 1×
“The marked increase in the extent of NAFLD worldwide is attributed to the rising prevalence of obesity and multiple coexisting metabolic risk factors [5–8].”
BackgroundObesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100 · cited 1×
“NAFLD also increases the risk of multiple cardiac and metabolic diseases [20].”
BackgroundNon‐alcoholic fatty liver disease
ANGULO, P., & LINDOR, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 835
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
Aithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721
Vuppalanchi, R., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.22603 · Cited by 563 · cited 1×
“This theory stems form the fact that insulin sensitisers, such as thiazolidinediones, have shown to provide, in addition to diabetes control, a resolution of NAFLD [25, 26].”
BackgroundGI Epidemiology: nonalcoholic fatty liver disease
ANGULO, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03246.x · Cited by 369 · cited 1×
“With the availability of modern diagnostic tools, NAFLD has become increasingly diagnosed and is currently considered the commonest liver disease worldwide [2–4].”
BackgroundMattar, S. G., Velcu, L. M., Rabinovitz, M., Demetris, A. J., Krasinskas, A. M., Barinas-Mitchell, E., Eid, G. M., Ramanathan, R., Taylor, D. S., & Schauer, P. R. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179652.07502.3f · Cited by 341 · cited 1×
“Only one of these studies, however, included LSG as an intervention for a total of 23 patients only [23].”
Background
Research works printed but not linked: 1
- Lee D (2007) Obesity can lead to fatty liver a silent killer, editorial review Aug 2007. http://www.medicinenet.com/script/main/art.asp?articlekey=46582 . Accessed 15 Feb 2015
Cited by
Evolution of NAFLD and Its Management
Mundi, M. S., Velapati, S., Patel, J., Kellogg, T. A., Abu Dayyeh, B. K., & Hurt, R. T. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10449 · Cited by 285
Fakhry, T. K., Mhaskar, R., Schwitalla, T., Muradova, E., Gonzalvo, J. P., & Murr, M. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.002 · Cited by 259
Koutoukidis, D. A., Koshiaris, C., Henry, J. A., Noreik, M., Morris, E., Manoharan, I., Tudor, K., Bodenham, E., Dunnigan, A., Jebb, S. A., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2020.154455 · Cited by 186
Laursen, T. L., Hagemann, C. A., Wei, C., Kazankov, K., Thomsen, K. L., Knop, F. K., & Grønbæk, H. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i2.138 · Cited by 176
Manco, M., Mosca, A., PEPPO, F. D., Caccamo, R., Cutrera, R., Giordano, U., Stefanis, C. D., Alisi, A., Baumann, U., Silecchia, G., et al. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.08.101 · Cited by 137
Metadata
- Authors
- Algooneh, A., Almazeedi, S., Al-Sabah, S., Ahmed, M., & Othman, F.
- Affiliations
- Amiri Hospital (KW)
- Corresponding author
- Al-Sabah, Salman
- Venue
- Surgical Endoscopy
- Published
- 2015-07-21
- Volume
- 30
- Issue
- 5
- Pages
- 1983-1987
- ISSN
- 0930-2794 (ISSN-L)
- 1432-2218
- OpenAlex
- W1866356053
- Cited by
- 36
- References
- 27
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 5 · 2021: 2 · 2020: 11 · 2019: 8 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 1
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Surgical Endoscopy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- non-alcoholic fatty liver disease, sleeve gastrectomy, laparoscopic bariatric surgery, morbid obesity, weight loss, excess weight loss, bariatric surgery outcomes
- MeSH terms
- Adolescent, Adult, Female, Follow-Up Studies, Gastrectomy, Humans, Liver, Male, Middle Aged, Obesity, Morbid, Laparoscopy, Postoperative Period, Retrospective Studies, Ultrasonography, Weight Loss, Body Mass Index, Multivariate Analysis, Treatment Outcome, Bariatric Surgery, Young Adult, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-alcoholic fatty liver disease resolution following sleeve gastrectomy. https://app.cochat.ai/papers/10.1007/s00464-015-4426-0
- The paper
- Algooneh, A., Almazeedi, S., Al-Sabah, S., Ahmed, M., & Othman, F. (2016). Non-alcoholic fatty liver disease resolution following sleeve gastrectomy. Surgical Endoscopy. https://doi.org/10.1007/s00464-015-4426-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.